Inhibitory effects on human gastric cancer cell line by MUC2 antisense oligodeoxynucleotide

XIAO Chunwei; et al

doi:10.13406/j.cnki.cyxb.2004.05.006

您当前的位置：

首页 >

文章列表页 >

Inhibitory effects on human gastric cancer cell line by MUC2 antisense oligodeoxynucleotide

更新时间：2024-01-17

- Inhibitory effects on human gastric cancer cell line by MUC2 antisense oligodeoxynucleotide
- Journal of Chongqing Medical University Issue 5, Pages: 580-584(2004)
- 作者机构：
  
  1. 重庆医科大学基础医学院病理学教研室
  2. 重庆医科大学基础医学院病理学教研室,重庆,400016
- 作者简介：
- 基金信息：
- DOI：10.13406/j.cnki.cyxb.2004.05.006
  CLC： R735.2
- Published：2004，
扫描看全文
[1]肖春卫,易永芬,林晓.粘蛋白MUC2反义核酸抑制胃癌细胞的研究[J].重庆医科大学学报,2004(05):580-584.

XIAO Chunwei, et al. Inhibitory effects on human gastric cancer cell line by MUC2 antisense oligodeoxynucleotide. [J]. Journal of Chongqing Medical University (5):580-584(2004)
[1]肖春卫,易永芬,林晓.粘蛋白MUC2反义核酸抑制胃癌细胞的研究[J].重庆医科大学学报,2004(05):580-584. DOI： 10.13406/j.cnki.cyxb.2004.05.006.

XIAO Chunwei, et al. Inhibitory effects on human gastric cancer cell line by MUC2 antisense oligodeoxynucleotide. [J]. Journal of Chongqing Medical University (5):580-584(2004) DOI： 10.13406/j.cnki.cyxb.2004.05.006.

摘要

目的 :探讨粘蛋白MUC2反义脱氧寡核苷酸（ASODN）对人胃癌细胞株SGC790 1的抑制作用。方法 :采用人工合成的MUC2ASODN经阳离子脂质体包裹后转染入胃癌株SGC790 1细胞

采用MTT法、形态学观察及免疫组化法测定MUC2ASODN对胃癌细胞的抑制作用。结果 :MTT法测细胞增殖活性见不同浓度ASODN均能抑制SGC790 1细胞的增殖

抑制作用在 4 8h最强

0 .5 μmol/LASODN对细胞的抑制率为 5 5 %

时间延长抑制作用逐渐减弱。SGC790 1细胞转染MUC2ASODN后

与对照组相比

光镜下观察到细胞数量减少、体积变小、核分裂明显减少、可见较多的变性、坏死。免疫组化S -P法染色提示转染ASODN后

SGC790 1细胞mRNA的翻译受到抑制

MUC2蛋白表达水平明显降低

p16蛋白表达明显增强

粘附分子CD4 4V6表达明显降低

MMP - 2的表达也显著下降

MMP - 9的表达无明显变化。结论 :使用人工合成MUC2ASODN能有效抑制胃癌细胞株SGC790 1的增殖及侵袭、转移潜能

Abstract

Objective:To investigate the inhibitory effect in vitro of mucin gene MUC2 antisense oligodeoxynucleotide (ASODN) on its gene expression and cell proliferation on gastric cancer cell line.Methods:Phosphorothioate MUC2 ASODN were synthesized and transfected to SGC7901 cells mediated by lipofectin.Their inhibitory effects on cell proliferation were determined by MTT method

light microscopy and immunohistochemical method.Results:The determination by MTT method demonstrated that MUC2 ASODN of varied concentrations could significantly inhibit the growth of SGC7901 cell lines while the control lipofectin showed no such effect.The result also suggested that the inhibitory effect was dose-dependent and time-dependent.The inhibition peaked at 48th hour after transfection

and the inhibition rate reached 55% when the concentration was 0.5μmol/L.After transfecting with MUC2 ASODN

SGC7901 cells showed decrease in number

volume and karyokinesis

increase in necroses under light microscopy.And the test by immunohistochemical method indicated that ASODN could downregulate the expression levels of MUC2 protein

MMP-2 protein and CD44V6 protein

but upregulate the expression levels of p16 protein.Conclusion:The data suggest that MUC2 ASODN transfection could effectively inhibit SGC7901 cells proliferation and invasion and metastasis potential of SGC7901 cells.

关键词

胃肿瘤MUC2反义寡核苷酸

Keywords

Stomach neoplasmsMUC2Antisense oligodeoxynucleotide

references

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Expression and significance of estrogen receptor in gastric carcinomas

The influence of antisense oligodeoxynucleotide targeting against telomerase in the expression of cellular oncogene to nasopharyngeal carcinoma cells

Effect of antisense oligodeoxynucleotide targeting against telomerase on proliferation of laryngeal carcinoma cells

Growth inhibition of nasopharyngeal carcinoma HNE-1 cell strain and effect on its tumorigenic ability by antisense oligodeoxynucleotide targeting telomerase RNA

Apoptosis of Eca-109 cells treated with antisense oligodeoxynucleotide targeting survivin and trichosanthin

Related Author

吴小翎

张小雨

骆文龙

et al

CAO Qian

曹前

吴家廉

et al

Related Institution

重庆医科大学第二临床学院消化内科

Department of Otorhinolaryngology,the Second College of Clinical Medicine,Chongqing Medical University

重庆医科大学第二临床学院耳鼻喉科

Deparment of Otorhinolaryngology, the Second College of Clinical Medicine, Chongqing Medical University

贵州安顺市第二人民医院五官科

⁰